New study aims to uncover why some patients suffer more after colorectal surgery
NCT ID NCT07219160
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study looks at why some people have more pain than others after colorectal surgery. Researchers will test pain sensitivity, analyze blood for inflammation, and ask about emotional health and life stress. The goal is to find better ways to manage pain and prevent long-term discomfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors identify patients at higher risk for severe pain after colorectal surgery and tailor pain management strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to understand pain, not to test a new drug or cure. Results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 128 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients scheduled to undergo colorectal surgery
- Ages
-
18 to 89 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants scheduled for colorectal cancer surgery * Age between 18-65; 3) * Understanding verbal and written English Exclusion Criteria: * Concurrent medical conditions that could confound the interpretation of the data * Human immunodeficiency virus positive diagnosis * Cardiovascular or pulmonary disease * Systemic rheumatoid disease * Uncontrolled hypertension (i.e. SBP/DBP of \> 150/95 * Current illness accompanied by fever (body temperature \>38 °C) * Any other chronic pain conditions * Conditions resulting in altered nerve sensation * Hospitalization due to psychiatric illness within the last 6 months * Poorly controlled diabetes * History of stroke * History of seizures * Circulatory disorders such AS Raynauds' disease * History of drug or alcohol abuse.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days
- The gatekeepers of tumors: scientists probe how blood vessels let immune cells in
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers